Copyright © 2005 Elsevier Ltd All rights reserved.
Gastrointestinal pharmacology: irritable bowel syndrome
Available online 26 September 2005.
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Over the past 30 years, the main treatment of irritable bowel syndrome has aimed to normalize gastrointestinal transit using either laxatives or antidiarrheal agents, with or without the concurrent use of spasmolytics. The recent introduction of serotonin-related drugs has stimulated investigations into the pathophysiology of irritable bowel syndrome, including an evaluation of visceral sensitivity. At the same time, more information has been acquired on the status of the local immune system as a possible cause for sensitization of nerve terminals. Such investigations have stimulated the emergence of new concepts and original candidate drugs for the treatment of this functional disorder. Particular attention is devoted to the correction of visceral hyperalgesia.







E-mail Article
Add to my Quick Links

Cited By in Scopus (6)





